Cargando…
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
Prostatic steroid 5-alpha-reductase gene (SRD5A2) encodes a critical enzyme involved in the conversion of testosterone to dihydrotestosterone. A germline mis-sense substitution (A49T) leads to a variant SRD5A2 protein, which has a 5-fold higher in vitro V (max) than the wild-type protein (Ross et al...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363646/ https://www.ncbi.nlm.nih.gov/pubmed/11355945 http://dx.doi.org/10.1054/bjoc.2001.1789 |
_version_ | 1782153756544073728 |
---|---|
author | Mononen, N Ikonen, T Syrjäkoski, K Matikainen, M Schleutker, J Tammela, T L J Koivisto, P A Kallioniemi, O P |
author_facet | Mononen, N Ikonen, T Syrjäkoski, K Matikainen, M Schleutker, J Tammela, T L J Koivisto, P A Kallioniemi, O P |
author_sort | Mononen, N |
collection | PubMed |
description | Prostatic steroid 5-alpha-reductase gene (SRD5A2) encodes a critical enzyme involved in the conversion of testosterone to dihydrotestosterone. A germline mis-sense substitution (A49T) leads to a variant SRD5A2 protein, which has a 5-fold higher in vitro V (max) than the wild-type protein (Ross et al, 1998; Makridakis et al, 1999). The A49T variant was recently associated with 2.5 to 3.28-fold increased risk of prostate cancer (PC) in African-American and Hispanic men (Makridakis et al, 1999). Also, Jaffe et al (2000) reported an association between A49T and more aggressive disease among Caucasian patients. Here, we report that the prevalence of the A49T variant in 449 Finnish PC patients was 6.0%, not significantly different from 6.3% observed in 223 patients with benign prostatic hyperplasia or 5.8% in 588 population-based controls (odds ratio for PC 1.04, 95% C.I. 0.62–1.76 P = 0.89). There was no association between A49T and the family history of the patients nor with tumour stage or grade. Our results argue against a prominent role of the A49T variant as a genetic risk factor for prostate cancer development and progression in the Finnish population. © 2001 Cancer Research Campaign www.bjcancer.com |
format | Text |
id | pubmed-2363646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23636462009-09-10 A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland Mononen, N Ikonen, T Syrjäkoski, K Matikainen, M Schleutker, J Tammela, T L J Koivisto, P A Kallioniemi, O P Br J Cancer Regular Article Prostatic steroid 5-alpha-reductase gene (SRD5A2) encodes a critical enzyme involved in the conversion of testosterone to dihydrotestosterone. A germline mis-sense substitution (A49T) leads to a variant SRD5A2 protein, which has a 5-fold higher in vitro V (max) than the wild-type protein (Ross et al, 1998; Makridakis et al, 1999). The A49T variant was recently associated with 2.5 to 3.28-fold increased risk of prostate cancer (PC) in African-American and Hispanic men (Makridakis et al, 1999). Also, Jaffe et al (2000) reported an association between A49T and more aggressive disease among Caucasian patients. Here, we report that the prevalence of the A49T variant in 449 Finnish PC patients was 6.0%, not significantly different from 6.3% observed in 223 patients with benign prostatic hyperplasia or 5.8% in 588 population-based controls (odds ratio for PC 1.04, 95% C.I. 0.62–1.76 P = 0.89). There was no association between A49T and the family history of the patients nor with tumour stage or grade. Our results argue against a prominent role of the A49T variant as a genetic risk factor for prostate cancer development and progression in the Finnish population. © 2001 Cancer Research Campaign www.bjcancer.com Nature Publishing Group 2001-05 /pmc/articles/PMC2363646/ /pubmed/11355945 http://dx.doi.org/10.1054/bjoc.2001.1789 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Mononen, N Ikonen, T Syrjäkoski, K Matikainen, M Schleutker, J Tammela, T L J Koivisto, P A Kallioniemi, O P A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland |
title | A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland |
title_full | A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland |
title_fullStr | A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland |
title_full_unstemmed | A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland |
title_short | A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland |
title_sort | missense substitution a49t in the steroid 5-alpha-reductase gene (srd5a2) is not associated with prostate cancer in finland |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363646/ https://www.ncbi.nlm.nih.gov/pubmed/11355945 http://dx.doi.org/10.1054/bjoc.2001.1789 |
work_keys_str_mv | AT mononenn amissensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT ikonent amissensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT syrjakoskik amissensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT matikainenm amissensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT schleutkerj amissensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT tammelatlj amissensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT koivistopa amissensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT kallioniemiop amissensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT mononenn missensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT ikonent missensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT syrjakoskik missensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT matikainenm missensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT schleutkerj missensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT tammelatlj missensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT koivistopa missensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland AT kallioniemiop missensesubstitutiona49tinthesteroid5alphareductasegenesrd5a2isnotassociatedwithprostatecancerinfinland |